Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by dardanion Aug 18, 2016 8:32am
173 Views
Post# 25153261

RE:RE:RE:Lung versus bladder?

RE:RE:RE:Lung versus bladder?Why they chose to go after bladder cancer first is nothing more complicated then they picked a part of the body their treatment could tackle the easiest. We only were informed recently that the clinical trial would include the dosimetry fiber optic cage but they must have been planning its inclusion for a long time. They just didn't publicly say much until the patent was a certainty. To me it looks to be a totally unsuitable method for lung cancer since the lungs are not like a spacious balloon which more describes a bladder. The lung has too many places where the cancer cells can hide so assuming they even get that far, they willl more than likely need to apply a custom procedure just for lungs. Again, we are putting the cart before the horse since they haven't even been given permission to hold a clinical trial yet. The subject of what cancer they will go after next is a moot point anyway because if their bladder cancer treatment works as effectively as some posters here speculate to cure bladder cancer than there will be no testing on lung, brain or whatever since the company will be quickly bought out by a pharma multi-national.
Bullboard Posts